Drug name - Acuvail
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7842714 | ALLERGAN | Ketorolac tromethamine compositions for treating ocular pain |
Aug, 2029
(6 years from now) | |
| CN102014869A | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Sep, 2015
(7 years ago) | |
| CN103976943B | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| CN103976943A | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| CN102497856B | ALLERGAN | For Treating Or Prevention Eye Pain Of Ketorolac Tromethamine Composition |
Aug, 2030
(7 years from now) | |
| CN102497856A | ALLERGAN | Ketorolac Tromethamine Composition For Treating Or Preventing Eye Pain |
Aug, 2030
(7 years from now) | |
| IN286644B | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| IN201006461P1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| EP2257275A2 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| EP2257275B1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| EP2446878B1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| EP2446878A1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Mar, 2029
(6 years from now) | |
| EP2473157A1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Aug, 2030
(7 years from now) | |
| EP2473157B1 | ALLERGAN | Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain |
Aug, 2030
(7 years from now) | |
| EP2555770B1 | ALLERGAN | Ketorolac Compositions For Corneal Wound Healing |
Apr, 2031
(8 years from now) | |
| EP2555770A1 | ALLERGAN | Ketorolac Compositions For Corneal Wound Healing |
Apr, 2031
(8 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8992952 | ALLERGAN | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
Aug, 2024
(1 year, 10 months from now) | |
| US9192571 | ALLERGAN | Ketorolac tromethamine compositions for treating or preventing ocular pain |
Mar, 2028
(5 years from now) | |
| US8512717 | ALLERGAN | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
Mar, 2028
(5 years from now) | |
Drugs and Companies using KETOROLAC TROMETHAMINE ingredient
Treatment: NA
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.45% | SOLUTION/DROPS;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.